Table 2 Sensitivity analysis of UCHL1 to commonly used drugs in the treatment of lung cancer
Compound | RNA type | RNA molecule | Omics | Source | Spearman | P* |
|---|---|---|---|---|---|---|
Perezone | mRNA | UCHL1 | Expression | CellMiner | − 0.533803875 | 0.006029875 |
Caracemide | mRNA | UCHL1 | Expression | CellMiner | − 0.482980911 | 0.007064843 |
Bafetinib | mRNA | UCHL1 | Expression | CellMiner | − 0.479686548 | 0.01466201 |
Palbociclib | mRNA | UCHL1 | Expression | CellMiner | − 0.407997669 | 0.031646287 |
Piperlongumine | mRNA | UCHL1 | Expression | GDSC | 0.08744003 | 0.035600008 |
Gefitinib | mRNA | UCHL1 | Expression | GDSC | 0.091381303 | 0.028871531 |
Embelin | mRNA | UCHL1 | Expression | GDSC | 0.097463539 | 0.047825308 |
Tipifarnib | mRNA | UCHL1 | Expression | GDSC | 0.110392871 | 0.019774916 |
Phenformin | mRNA | UCHL1 | Expression | GDSC | 0.110531447 | 0.001943254 |
Bosutinib | mRNA | UCHL1 | Expression | GDSC | 0.115226293 | 0.003381483 |